Sociodemographic Determinants of Willingness and Extent to Pay for COVID-19 Vaccine in India.
COVID-19
India
sociodemographic factors
vaccine
willingness to pay
Journal
Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579
Informations de publication
Date de publication:
2022
2022
Historique:
received:
07
02
2022
accepted:
12
04
2022
entrez:
23
6
2022
pubmed:
24
6
2022
medline:
25
6
2022
Statut:
epublish
Résumé
Responding to the fast transmission rates and increasing fatality rates, countries across the world expedited the development and deployment of the vaccine for coronavirus disease 2019 (COVID-19). Evaluation of individuals' willingness to pay (WTP) would provide pertinent information regarding future demand and financing preferences, which shall help to devise the effective payment strategy for COVID-19 vaccination. A nationwide, cross-sectional, and self-administered online survey using a structured questionnaire was conducted to identify the sociodemographic determinants of willingness and extent to pay for COVID-19 vaccine in India. A non-probability convenience sampling followed by snowball sampling was employed to recruit participants ( Out of 3,341 participants, 68% ( This study observed that majority of those participants who willingness to pay for COVID-19 vaccine were willingness to pay only up to 50% of COVID-19 vaccine and income was observed as a precursor predictor of the willingness and extent to pay for COVID-19 vaccine. The understanding on the willingness and extent to pay for COVID-19 vaccine and its sociodemographic determinants will be helpful for making the strategic decisions related to the financing of COVID vaccine in India.
Sections du résumé
Background
Responding to the fast transmission rates and increasing fatality rates, countries across the world expedited the development and deployment of the vaccine for coronavirus disease 2019 (COVID-19). Evaluation of individuals' willingness to pay (WTP) would provide pertinent information regarding future demand and financing preferences, which shall help to devise the effective payment strategy for COVID-19 vaccination.
Methods
A nationwide, cross-sectional, and self-administered online survey using a structured questionnaire was conducted to identify the sociodemographic determinants of willingness and extent to pay for COVID-19 vaccine in India. A non-probability convenience sampling followed by snowball sampling was employed to recruit participants (
Results
Out of 3,341 participants, 68% (
Conclusion
This study observed that majority of those participants who willingness to pay for COVID-19 vaccine were willingness to pay only up to 50% of COVID-19 vaccine and income was observed as a precursor predictor of the willingness and extent to pay for COVID-19 vaccine. The understanding on the willingness and extent to pay for COVID-19 vaccine and its sociodemographic determinants will be helpful for making the strategic decisions related to the financing of COVID vaccine in India.
Identifiants
pubmed: 35734756
doi: 10.3389/fpubh.2022.870880
pmc: PMC9207713
doi:
Substances chimiques
COVID-19 Vaccines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
870880Commentaires et corrections
Type : ErratumIn
Informations de copyright
Copyright © 2022 Kiran, Junaid, Sharma, Jain, Vij, Satapathy, Chakrapani, Patro, Kar, Singh, Pala, Bali, Rustagi, Goel, Sankhe, Modi, Gupta, Aggarwal, Rajagopal and Padhi.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Eur J Epidemiol. 2020 Aug;35(8):775-779
pubmed: 32785815
Hum Vaccin Immunother. 2017 Apr 3;13(4):786-790
pubmed: 27905832
Vaccine. 2014 Jul 31;32(35):4471-4477
pubmed: 24968160
Singapore Med J. 2005 Jun;46(6):259-68; quiz 269
pubmed: 15902353
PLoS Negl Trop Dis. 2020 Dec 17;14(12):e0008961
pubmed: 33332359
PLoS One. 2021 Jun 24;16(6):e0253499
pubmed: 34166399
Appl Health Econ Health Policy. 2021 May;19(3):343-351
pubmed: 33619688
Hum Vaccin Immunother. 2020 Sep 1;16(9):2204-2214
pubmed: 32730103
Front Public Health. 2021 Dec 15;9:735902
pubmed: 34976911
Vaccine. 2020 Jul 22;38(34):5424-5429
pubmed: 32620375
Vaccine. 2020 Dec 3;38(51):8090-8098
pubmed: 33187765
Hum Vaccin Immunother. 2020 Dec 1;16(12):3074-3080
pubmed: 32991230
Hum Vaccin Immunother. 2021 Dec 2;17(12):4904-4913
pubmed: 34757868
Int J Soc Psychiatry. 2020 Jun;66(4):317-320
pubmed: 32233719
Vaccine. 2021 Apr 1;39(14):1968-1976
pubmed: 33714653